why choose us

First received: April 25, 2024

Clinical Trial: The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Vasospastic Angina

Study Type: INTERVENTIONAL


Official Title: Vericiguat in Vasospastic Angina

Brief Summary: Vasospastic angina is increasingly recognized as an important contributor to anginal symptoms in patients with non-obstructive coronary artery disease (ANOCA). Endothelial dysfunction and smooth muscle cell dysfunction are considered elementary in the development of vasospastic angina. As one of many functions, the vascular endothelium regulates local vascular tone, mainly through the vasodilatory effect of endothelium-derived nitric oxide (NO). Vericiguat is a soluble guanylate cyclase (sGC) stimulator and…

Read more